Table 1.
Patient background characteristics included in this study
| Total, n = 47 | ||
|---|---|---|
| General background | ||
| Age (y) § | 73 (69–80) | |
| Sex, n | Male / Female | 35 (74) / 12 (26) |
| BMI (kg/m2) § | 22.6 (20.7–24.8) | |
| Performance status, n | 0 / 1 / 2 / 3 | 41 (87) / 5 (11) / 1 (2) / 0 (0) |
| Underlying liver disease, n | HB, HC / non-B non-C | 26 (55) / 21 (45) |
| Child-Pugh classification, n | A / B | 47 (100) / 0 (0) |
| Blood examination | ||
| AST (IU/L) § | 25 (22–47) | |
| ALT (IU/L) § | 25 (15–53) | |
| Serum albumin (g/dL) § | 4.1 (3.8–4.4) | |
| Serum total bilirubin (mg/dL) § | 0.7 (0.6–1.0) | |
| Prothrombin time (%) § | 102 (93–107) | |
| Platelet count (× 103mm3) § | 20.4 (15.8–23.9) | |
| ICG R15 (%) § | 9.8 (7.1–13.4) | |
| Tumor factor | ||
| Diagnosis, n | HCC / Metastasis / ICC / others | 34 (72) / 6 (13) / 3 (6) / 4 (9) |
| Tumor size (cm) § | 3.5 (2.5–5.5) | |
| Tumor number, n (%) | 1 / ≥ 2 | 36 (77) / 11 (23) |
| Macrovascular invasion, n | 7 (15) |
Values in parentheses are percentages unless indicated otherwise; §values are median (interquartile range)
ALT, alanine transaminase; AST, aspartate aminotransferase; BMI, body mass index; HB, hepatitis B; HC, hepatitis C; HCC, hepatocellular carcinoma; ICC, intrahepatic cholangiocarcinoma; ICGR15, indocyanine green retention time at 15 min; non-B non-C, nonhepatitis B and nonhepatitis C